NVS Chart
- 52-Week Range: $76.50 - $93.75
- Market Capitalization: $200.15B
- Short Percentage: 0%
- Target Price: $104.40
- Shares Outstanding: 2.21B
- Next Earnings: Feb 2
Catalysts
CategoryCatalyst
Earnings
NVS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?The Motley Fool | March 19th
- Earnings Previews: AbbVie, Humana, Marathon Petroleum, Novartis24/7 Wall Street | January 31st
- Vera: Biotech With 3 Mid-Stage Programs With Potential For SuccessSeeking Alpha | January 19th
- Surface Oncology: If Novartis, GlaxoSmithKline And ARK See Promise, So Do ISeeking Alpha | January 18th
Company Info
Website: https://www.novartis.com
Address: Lichtstrasse 35, Basel, Switzerland, 4056
Sector: Healthcare
Industry: Drug Manufacturers—General
Full time employees: 110,000
Address: Lichtstrasse 35, Basel, Switzerland, 4056
Sector: Healthcare
Industry: Drug Manufacturers—General
Full time employees: 110,000
$NVS to the moon!
$NVS HODL
$NVS 5 minute looks sexy
$NVS hold
$NVS we like the stock
$NVS Longs will be rewarded handsomely
$NVS the catalyst we need !
$NVS wow! I sold too early
$NVS nearing a decent swing entry point
$NVS How can this stock move so little? Damn